Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Amiri

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Immunotherapy|July 9, 2013
Construction and characterization of a new chimeric antibody against HER2Mohammad Mehdi Amiri, Mahmood Jeddi-Tehrani, Tohid Kazemi, et al.
Iranian Journal of Immunology : IJI|October 1, 2013
Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesisForough Golsaz Shirazi, Mohammad Mehdi Amiri, Hamed Mohammadi, et al.
Analytical Biochemistry|February 8, 2023
Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2Hamidreza Yadegari, Mehdi Mohammadi, Faezeh Maghsood, et al.
Pathogens and Disease|January 7, 2022
Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patientsFaezeh Maghsood, Mohammad-Reza Shokri, Mahmood Jeddi-Tehrani, et al.
Nucleic Acids Research|May 9, 2023
The ribosome quality control factor Asc1 determines the fate of HSP70 mRNA on and off the ribosomeLokha R Alagar Boopathy, Emma Beadle, Alan RuoChen Xiao, et al.
Viral Immunology|October 2, 2015
Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface AntigenForough Golsaz-Shirazi, Mohammad Mehdi Amiri, Motahareh Bahadori, et al.
Iranian Journal of Immunology : IJI|May 7, 2023
Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue SamplesMasoud Hassanzadeh Makoui, Maryam Mobini, Jalal Khoshnoodi, et al.
Investigational New Drugs|October 7, 2017
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibitionMohammad Mehdi Amiri, Forough Golsaz-Shirazi, Tahereh Soltantoyeh, et al.
Investigational New Drugs|January 3, 2021
Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft modelsFariba Shiravi, Mehdi Mohammadi, Forough Golsaz-Shirazi, et al.
Frontiers in Immunology|March 8, 2021
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects <i>In Vitro</i> and <i>In Vivo</i>Mehdi Mohammadi, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Immunotherapy|July 9, 2013
Construction and characterization of a new chimeric antibody against HER2Mohammad Mehdi Amiri, Mahmood Jeddi-Tehrani, Tohid Kazemi, et al.
Iranian Journal of Immunology : IJI|October 1, 2013
Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesisForough Golsaz Shirazi, Mohammad Mehdi Amiri, Hamed Mohammadi, et al.
Analytical Biochemistry|February 8, 2023
Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2Hamidreza Yadegari, Mehdi Mohammadi, Faezeh Maghsood, et al.
Pathogens and Disease|January 7, 2022
Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patientsFaezeh Maghsood, Mohammad-Reza Shokri, Mahmood Jeddi-Tehrani, et al.
Nucleic Acids Research|May 9, 2023
The ribosome quality control factor Asc1 determines the fate of HSP70 mRNA on and off the ribosomeLokha R Alagar Boopathy, Emma Beadle, Alan RuoChen Xiao, et al.
Viral Immunology|October 2, 2015
Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface AntigenForough Golsaz-Shirazi, Mohammad Mehdi Amiri, Motahareh Bahadori, et al.
Iranian Journal of Immunology : IJI|May 7, 2023
Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue SamplesMasoud Hassanzadeh Makoui, Maryam Mobini, Jalal Khoshnoodi, et al.
Investigational New Drugs|October 7, 2017
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibitionMohammad Mehdi Amiri, Forough Golsaz-Shirazi, Tahereh Soltantoyeh, et al.
Investigational New Drugs|January 3, 2021
Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft modelsFariba Shiravi, Mehdi Mohammadi, Forough Golsaz-Shirazi, et al.
Frontiers in Immunology|March 8, 2021
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects <i>In Vitro</i> and <i>In Vivo</i>Mehdi Mohammadi, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, et al.
Pageof 11